Feinstein Center

The people have spoken: It’s 3D-printed tissue

With nearly half-a-million votes cast, Northwell Health is ready to declare a 3D bioprinting project the winner of its $100,000 Medical Innovation Contest. The month-long multimedia contest, featuring television commercials and online voting, asked the public to choose from three healthcare innovations developed by Northwell researchers and physicians, with the winner receiving the six-figure stipend to bolster commercialization efforts. Northwell Health President and CEO Michael Dowling on Monday presented the winner’s share to Lee Smith,…


A promising future treatment for lupus

By GREGORY ZELLER // There’s a long tunnel ahead, but for millions around the world suffering from lupus, the light at the end shines brightly. That’s the fervent belief of Meggan Mackay, a board-certified rheumatologist and assistant professor at the Hofstra Northwell School of Medicine. Mackay is initiating a Phase 2 clinical trial of a drug she says might rival today’s best treatments for the autoimmune disease but without the devastating side effects. There’s no…


Israel, state officials call for Alzheimer’s initiative

U.S. Rep. Steve Israel and State Assemblyman Charles Lavine joined forces at North Shore-LIJ’s Feinstein R&D center on Tuesday to renew a call to turn the Empire State into a national focal point for Alzheimer’s disease research. Joining the pair: State Sen. David Carlucci, a Democrat from mid-state Clarkstown. The initiative, according to the lawmakers, would mirror California’s approach to stem cell research and that state’s 2004 Stem Cell Research and Cures Act, which among…


Symbiotoc Health CEO Gerard Honig

Symbiotic Health gets $100K in funding

By GREGORY ZELLER // A spinoff of the Feinstein Institute for Medical Research has snagged a critical $100,000 stake from Accelerate Long Island and the Long Island Emerging Technologies Fund – good news for anyone suffering from the most prevalent hospital-based infection in the United States. Symbiotic Health, which does battle against the insidious Clostridium difficile infection, announced today that Accelerate Long Island has matched the $50,000 investment the LIETF fund made in June –…


SetPoint Medical

Feinstein’s vagus research takes plenty of nerve

BY GREGORY ZELLER // What happens in vagus doesn’t actually stay there. Or at least that’s the theory behind electrical stimulation of the vagus nerve, a long cranial bundle that extends from the brain to the abdomen. Medical science is just scratching the surface of the therapeutic value of vagus stimulation, but new studies suggest it goes far beyond the treatment of certain forms of epilepsy and depression, two longstanding targets of vagus manipulation. Dr….


Symbiotoc Health CEO Gerard Honig

Leading the fight against C. Diff

By GREGORY ZELLER // Researchers battling the insidious clostridium difficile infection are making progress on several new fronts, including a novel “poop pill” developed by Symbiotic Health, a spinoff from North Shore-LIJ’s Feinstein Institute. C. Diff, as it is known, is the most prevalent hospital-acquired infection in the United States and “an immediate public health threat,” according to the Centers for Disease Control. The infection attacks the gastrointestinal tract when broad-spectrum antibiotics fight off infections but…